Emtux 500 mg Injection
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Emtux 500 mg Injection

Emtux 500 mg Injection

Emtux 500 mg Injection contains rituximab and is a monoclonal antibody used to treat certain blood cancers and autoimmune disorders. It works by targeting CD20-positive B cells and helping the immune system destroy abnormal cells. The injection is administered as an intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Rituximab binds to the CD20 protein found on B cells and supports their removal through immune-mediated mechanisms. Emtux 500 mg Injection is used in treatment regimens for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and selected autoimmune disorders. The medicine is supplied as a 50 mL vial containing 500 mg of rituximab and requires controlled handling and administration in a healthcare setting. Patients may require monitoring for infusion reactions, infections, blood counts, and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Dosage Form Injection
Concentration 10 mg/mL
Fill Volume 50 mL
Route of Administration Intravenous infusion

Product Also Known As

Emtux 500 mg, Emtux 500 mg Injection, Emtux 500 mg/50 mL, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL, Rituximab Injection, Anti-CD20 Monoclonal Antibody